AKT1 and renal cell carcinoma: On the other hand, the lncRNA ARSR (Activated in renal cell carcinoma (RCC) with Sunitinib Resistance, ENST00000424980) promotes hepatic cholesterol biosynthesis via Akt/SREBP-2/HMGCR modulation.